The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This analysis of flu vaccination rates across states and across groups within each state highlights some of the challenges facing public health officials in ensuring most people receive a COVID-19 vaccine when one becomes available.
The American Association for the Advancement of Science (AAAS) has awarded KFF’s Kaiser Health News and The Associated Press one of its top journalism prizes for a joint investigation that revealed the diminished state of the U.S. public health infrastructure in the face of the COVID-19 pandemic.
KHN and Gray Television’s InvestigateTV team joined forces to dig into the underlying reasons why strokes are a deadlier threat across most counties in Appalachia and the Mississippi Delta, rural regions that are characterized by high rates of poverty, vulnerable elderly populations, a shortage of medical providers and an epidemic of local hospital closures.
With supply having increased significantly and eligibility fully open to adults in all states as of April 19, this analysis estimates that COVID-19 vaccine supply will exceed demand across the U.S. over the next 2 to 4 weeks.
Despite Optimism about COVID-19 Vaccines in the Future, Half Say They are Frustrated with the Current Situation and Nearly a Quarter are Angry While older Americans are a high-priority group for getting a COVID-19 vaccine, the latest KFF COVID-19 Vaccine Monitor report finds that, among those who have not yet been vaccinated, most people ages 65 and…
As the country broadens COVID-19 vaccine distribution efforts, the latest research from the KFF COVID-19 Vaccine Monitor finds that side effects, including allergic reactions and long-term consequences, are the public’s top concern about getting vaccinated when asked to describe what worries them in their own words.
Nearly a third (31%) of the public says they want to “wait and see” how a COVID-19 vaccine works for others before they would get it, representing a critical group for efforts aimed at boosting vaccinations.
This Policy Watch examines how the 50 states and DC are defining “high-risk medical conditions” for COVID-19 vaccine prioritization, including whether they follow CDC’s recommendations or deviate in some way.
This policy watch looks at the expected ramp up in vaccine supply, and what this could mean for increasing the number of people getting vaccinated.
As states continue to ease social distancing restrictions, Americans are leaving their homes more often to shop, visit close family and friends and go to work than they did in April in spite of their concerns about contracting coronavirus, the latest KFF tracking poll finds.
© 2025 KFF
